In contrast, our MTS AAV approach resulted in expression of mutant human ND4 in mitochondria where it induced visual loss and optic atrophy, thus suggesting that our novel technology may also be useful long after birth for inserting DNA into the mitochondria of live animals. The gene discussed is MT-ND4; the disease is optic atrophy.